Study of patient experiences in immunotherapy clinical trials
Part of Cancer clinical trials.
This study asks people with cancer about their experiences when joining an immunotherapy (a cancer treatment that helps the immune system fight cancer) clinical trial. It may help the researchers understand what patients experience during these trials and improve how trials support patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer and are planning to join an interventional immunotherapy clinical trial
- You are 18 years old or older
- Your health status is not extremely poor (ECOG score less than 4)
- You can reliably complete online or phone reporting the study requires
- You can and do sign the informed consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches immune system markers to see if they can predict which patients will respond well to immunotherapy and who might have side effects. If you have cancer and are starting immunotherapy, this trial may help guide future treatment decisions.
This study looks at how people’s bodies respond to cancer immunotherapy and why some people get side effects. Your information and lab results may help improve how immunotherapy is managed in the future.
This is an observational study that follows adults with solid cancer who are receiving immune checkpoint inhibitor treatments. It aims to learn how these medicines are used and what outcomes may look like in everyday care.
This trial studies how changing your immune system (with earlier treatments) affects cancer by collecting immune cells from your blood using a process called lymphapheresis. It may help researchers find better ways to monitor immune-related responses and side effects.
This study sets up a real-world patient database to follow people starting cancer immunotherapy and record immune-related side effects. You may help doctors better understand who gets these side effects and how they change over time.
This study looks at side effects from immunotherapy in people with solid or blood cancers. It may help doctors better manage these side effects in the future.
Hear when a new Immunotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.